Lung cancer is an abnormal growth of cells that originates in the lung. Approximately 180,000 new cases are diagnosed each year
in the United States.
The comprehensive Lung/Thoracic Cancer Program at St. Luke’s brings together a team of highly skilled cancer experts to ensure
people with lung cancer receive the best course of treatment and the hope, reassurance and confidence needed to fight the
disease to the fullest.
St. Luke’s is committed to leading-edge, patient-centered and research-driven lung cancer care, offering minimally invasive
cancer resections, the most up-to-date targeted chemotherapy, and the latest in stereotactic radiation.
All new cases of known or suspected lung cancer are reviewed in a weekly multidisciplinary conference where general thoracic
surgeons, pulmonologists, medical oncologists, radiation oncologists, pathologists and radiologists meet to agree upon the
optimal treatment plan for each individual patient. Each week, every patient undergoing active lung cancer treatment at
St. Luke’s is reviewed by the Lung Cancer Working Group to assess their progress.
Close